Quantcast

Posts related to ‘Pandemic Flu’

BioCryst Botched Flu Results (BCRX)

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has announced preliminary findings from a Phase II study with intramuscular injection of Peramivir, the Company's product candidate for the treatment of seasonal and life-threatening ...
Read Full Story »